Literature DB >> 29725861

Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives.

Md Sadikuj Jaman1, Md Abu Sayeed2.   

Abstract

Globally, breast cancer is the most common cancer and the second leading cause of cancer-related death among women. Surgery, chemotherapy, hormonal therapy, and radiotherapy are currently available treatment options for breast cancer therapy. However, chemotherapy, hormonal therapy, and radiotherapy are often associated with side effects and multidrug resistance, recurrence, and lack of treatment in metastasis are the major problems in the treatment of breast cancer. Recently, dietary phytochemicals have emerged as advantageous agents for the prevention and therapy of cancer due to their safe nature. Ellagic acid (EA), sulforaphane (SF), and ursolic acid (UA), which are found in widely consumed fruits and vegetables, have been shown to inhibit breast cancer cell proliferation and to induce apoptosis. This review encompasses the role of EA, SF, and UA in the fight against breast cancer. Both in vitro and in vivo effects of these agents are presented.

Entities:  

Keywords:  Breast cancer; Ellagic acid; In vitro; In vivo; Sulforaphane; Ursolic acid

Mesh:

Substances:

Year:  2018        PMID: 29725861     DOI: 10.1007/s12282-018-0866-4

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  12 in total

1.  Ellagic acid and human cancers: a systems pharmacology and docking study to identify principal hub genes and main mechanisms of action.

Authors:  Hamid Cheshomi; Ahmad Reza Bahrami; Maryam M Matin
Journal:  Mol Divers       Date:  2020-05-14       Impact factor: 2.943

Review 2.  The Glucosinolates: A Sulphur Glucoside Family of Mustard Anti-Tumour and Antimicrobial Phytochemicals of Potential Therapeutic Application.

Authors:  James Melrose
Journal:  Biomedicines       Date:  2019-08-19

Review 3.  A Review of Cytotoxic Plants of the Indian Subcontinent and a Broad-Spectrum Analysis of Their Bioactive Compounds.

Authors:  Kishor Mazumder; Biswajit Biswas; Iqbal Mahmud Raja; Koichi Fukase
Journal:  Molecules       Date:  2020-04-20       Impact factor: 4.411

4.  Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.

Authors:  Yu-Ning Teng; Charles C N Wang; Wei-Chieh Liao; Yu-Hsuan Lan; Chin-Chuan Hung
Journal:  Molecules       Date:  2020-01-07       Impact factor: 4.411

5.  Precision Nutrition and Cancer Relapse Prevention: A Systematic Literature Review.

Authors:  Clara Reglero; Guillermo Reglero
Journal:  Nutrients       Date:  2019-11-16       Impact factor: 5.717

Review 6.  Smart Responsive Nanoformulation for Targeted Delivery of Active Compounds From Traditional Chinese Medicine.

Authors:  Xuejun Jiang; Mei Lin; Jianwen Huang; Mulan Mo; Houhe Liu; Yuan Jiang; Xiaowen Cai; Wingnang Leung; Chuanshan Xu
Journal:  Front Chem       Date:  2020-12-10       Impact factor: 5.221

Review 7.  Current Perspectives of the Applications of Polyphenols and Flavonoids in Cancer Therapy.

Authors:  Xavier Montané; Oliwia Kowalczyk; Belen Reig-Vano; Anna Bajek; Krzysztof Roszkowski; Remigiusz Tomczyk; Wojciech Pawliszak; Marta Giamberini; Agnieszka Mocek-Płóciniak; Bartosz Tylkowski
Journal:  Molecules       Date:  2020-07-23       Impact factor: 4.411

8.  Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.

Authors:  Alon Ben David; Eran Diamant; Eyal Dor; Ada Barnea; Niva Natan; Lilach Levin; Shira Chapman; Lilach Cherry Mimran; Eyal Epstein; Ran Zichel; Amram Torgeman
Journal:  Molecules       Date:  2021-05-27       Impact factor: 4.411

9.  ROS-responsive dimeric prodrug-based nanomedicine targeted therapy for gastric cancer.

Authors:  Jiachi Ma; Yuzhong Chen; Wanqing Liang; Lei Li; Jun Du; Chengwu Pan; Chensong Zhang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 10.  The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence.

Authors:  Tzu-Ying Lee; Yu-Hsin Tseng
Journal:  Biomolecules       Date:  2020-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.